Austin Reeves
Podiatrist · Texarkana, TXNPI 1962408674
Payments from drug & device makers
What this record shows
This record is dominated by other: $31,142 of the $32,683 with a category attached, or 95.3%. Convatec Inc. accounts for 95.3% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $19,000, more than ten times the $1,134 reported in 2019. Among podiatrist clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 28 payments — averaging $1167.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$31K
- Pylant Medical$1K
- Paratek Pharmaceuticals, Inc.$126
- Triad Life Sciences Inc.$100
- Tactile Systems Technology Inc$70
- Boston Scientific$63
- plus $66 from 3 others
What the payments were for
- Food & beverage$4261%
- Education$1,1153%
- Other$31,14295%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 6 | $31,142 |
| Pylant Medical | 1 | $1,115 |
| Paratek Pharmaceuticals, Inc. | 7 | $126 |
| Triad Life Sciences Inc. | 5 | $100 |
| Tactile Systems Technology Inc | 5 | $70 |
| Boston Scientific | 1 | $63 |
| Johnson & Johnson | 1 | $30 |
| Melinta Therapeutics, LLC | 1 | $19 |
| Baudax Bio Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$31,142
How this compares
$32,683 in reported general payments places this provider in the 90th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine-PrilocaineLidocaine/Prilocaine | 25 | $1,267 |
| Terbinafine Hcl | 58 | $1,203 |
| Pregabalin | 20 | $534 |
| Ketorolac Tromethamine | 27 | $427 |
| Gabapentin | 40 | $388 |
| Indomethacin | 35 | $186 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $147 |
| Nystatin | 11 | $139 |
| Ciprofloxacin Hcl | 11 | $109 |
| Triamcinolone Acetonide | 14 | $99 |
| Allopurinol | 12 | $86 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Texarkana
- Brian CarpenterFort Worth$1.2M
- Gary LepowHouston$1M
- Wayne HurstCedar Park$625K
- Calvin RushingSunnyvale$452K
- Alan GarrettFort Worth$185K
- Gregory JarygaFt Worth$175K
- Brandon LampeMesquite$154K
- Andrew SchneiderHouston$150K
- Patrick BriggsWebster$133K
- Richard AdamsGranbury$130K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.